Immunotherapy and Emerging Therapeutic Innovations

Immunotherapy is reshaping the future of breast cancer treatment by harnessing the body's immune system to recognize and eliminate cancer cells. This track will examine immune checkpoint inhibitors, cancer vaccines, adoptive cell therapies, antibody-drug conjugates, bispecific antibodies, CAR-T cell research, and combination treatment strategies. Discussions will focus on predictive biomarkers, tumor immunology, mechanisms of immune resistance, and strategies for improving therapeutic response. Experts will present the latest clinical evidence, ongoing research, and future directions in immuno-oncology, highlighting how innovative therapies are expanding treatment options and advancing precision medicine for patients with breast cancer.

 

    Related Conference of Immunotherapy and Emerging Therapeutic Innovations

    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    August 10-11, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    September 07-08, 2026

    26th World Congress on Cancer and Diagnostics

    Paris, France
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    October 05-06, 2026

    22nd International Conference on Cancer Research

    Madrid, Spain
    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    November 24-25, 2026

    6th International Conference on Oncology and Cancer

    Paris, France
    December 08-09, 2026

    27th World Congress on Cancer Summit

    Paris, France
    December 08-09, 2026

    14th Euro Breast Cancer and Therapeutics

    Paris, France

    Immunotherapy and Emerging Therapeutic Innovations Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in